This fall marks the 15th anniversary of the U.S. anthrax letter attacks that sickened dozens of people and killed five. At the time, there was no effective treatment for a late stage infection. The attacks accelerated work already underway at the University of Texas at Austin. Brent Iverson, George Georgiou and Jennifer Maynard borrowed a page from Mother Nature's playbook to develop the world's first treatment for late stage inhalation anthrax.
Alzheimer's disease, the sixth leading cause of death in the United States, has proven especially thorny for researchers: no cure has been found, nor has there been any treatment proven to slow the progression of the disease once it sets in. In a new study published in the Proceedings of the National Academy of Sciences, scientists have taken a back-to-the-beginning approach, examining what happens at the start of a chain reaction that occurs before onset of the disease.
Faculty members in the College of Natural Sciences are leading new Pop-Up Institutes as part of a new interdisciplinary research initiative at The University of Texas at Austin. Three Pop-Up Institutes were announced this week, with two originating in Natural Sciences. These research efforts will assemble fresh collaborations to address the influence of individual variation on the health and fitness of populations and the impact of discrimination on health outcomes.
Some of the bacteria in our guts were passed down over millions of years, since before we were human, suggesting that evolution plays a larger role than previously known in people's intestinal-microbe makeup, according to a new study in the journal Science.
Researchers from The University of Texas at Austin and elsewhere have determined that two bacterial species commonly found in the human mouth and in abscesses, cooperate to make the pathogenic bacterium, Aggregatibacter actinomycetemcomitans, more infectious. Key to the cooperation is that the harmless partner provides the pathogen with an oxygen-rich environment that helps it flourish.
Scientists at The University of Texas at Austin have developed a new method to rapidly detect a single virus in urine, as reported this week in the journal Proceedings of the National Academy of Sciences.
Rachel Graubard and Vatsal Shah, both alumni of the Freshman Research Initiative's DIY Diagnostics stream, have created two apps which could help patients detect skin cancer at home.
David Herrin, University of Texas at Austin professor of molecular biosciences, led a team of researchers which has developed algae that produce chemicals toxic to disease-carrying mosquitoes.
Researchers at The University of Texas at Austin successfully culminated years of work when a drug they engineered for the treatment and prevention of inhalational anthrax — the anthrax antitoxin obiltoxaximab — received approval March 21 from the U.S. Food and Drug Administration (FDA).